symp1

0

W.H. Moolenaar (The Netherlands): Identification of EDG receptors as receptors for lysophospholipids. Molecular characteristics and cellular signalling.

K. Liliom (Hungary): Pharmacological properties of EDG receptors.

I. Gennero (France): The vascular smooth muscle as a target for lysophospholipids.

K. Racké (Germany): Differential expression and function of EDG rectors in inflammatory cells.

M.S. Beer (U.K.): EDG receptors as therapeutic target in the nervous system.